nicotinic acid/гојазност

Веза се чува у привремену меморију

Изаберите тип сортирања

Страна 1 од 100 резултати

Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker Rats.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Inclusion of stochastic differential equations in mixed effects models provides means to quantify and distinguish three sources of variability in data. In addition to the two commonly encountered sources, measurement error and interindividual variability, we also consider uncertainty in the

Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

This study investigates the impact of disease on nicotinic acid (NiAc)-induced changes in plasma concentrations of non-esterified fatty acids (NEFA). NiAc was given by constant intravenous infusion to normal Sprague-Dawley and obese Zucker rats, and arterial blood samples were taken for analysis of

Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Data were pooled from several studies on nicotinic acid (NiAc) intervention of fatty acid turnover in normal Sprague-Dawley and obese Zucker rats in order to perform a joint PKPD of data from more than 100 normal Sprague-Dawley and obese Zucker rats, exposed to several administration routes and

Nicotinic Acid Accelerates HDL Cholesteryl Ester Turnover in Obese Insulin-Resistant Dogs.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

OBJECTIVE Nicotinic acid (NA) treatment decreases plasma triglycerides and increases HDL cholesterol, but the mechanisms involved in these change are not fully understood. A reduction in cholesteryl ester transfer protein (CETP) activity has been advanced to explain most lipid-modulating effects of

Nicotinic acid decreases apolipoprotein B100-containing lipoprotein levels by reducing hepatic very low density lipoprotein secretion through a possible diacylglycerol acyltransferase 2 inhibition in obese dogs.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Apolipoprotein B100 (apoB100) is an essential component of very low density lipoprotein (VLDL) and low-density lipoprotein (LDL), both independent markers of cardiovascular risk. Nicotinic acid (NA) is an efficacious drug for decreasing VLDL and LDL, but the underlying mechanisms are unclear. For

Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Nicotinic acid (NiAc) is a potent inhibitor of lipolysis, acutely reducing plasma free fatty acid (FFA) concentrations. However, a major FFA rebound is seen during rapid NiAc washout, and sustained exposure is associated with tolerance development, with FFAs returning to pretreatment levels. Our aim

[Effect of nicotinic acid and adrenaline on plasmatic concentration of NEFA and blood sugar in obese children].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

[Effects of nicotinic acid on the secretion of HGH in normal and obese subjects].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

[Effect of nicotinic acid on metabolic phenomena caused by anaerobic work in obese subjects].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Metabolic changes induced by a nicotinic acid derivative in patients with obesity grades 1, 2 and 3.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Effect of nicotinic acid administaation on plasma HGH, FFA and glucose in obese subjects and in hypopituitary patients.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Anti-diabetic effect of trigonelline and nicotinic acid, on KK-A(y) mice.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Trigonelline (TRG) and nicotinic acid (NA), in which the former but not the latter improved the blood glucose level in the oral glucose tolerance test (OGTT) in Goto-Kakizaki (GK) rats were tested for anti-diabetic effects in mellitus models of KK-A(y) obese mice that had type 2 diabetes. Blood

[Innovative therapies in metabolic diseases: ezetimibe (Ezétrol), nicotinic acid (Niaspan), acids omega-3 (Omacor), rimonabant (Acomplia)].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

In the field of dyslipidemia and metabolic syndrome, four innovative therapies are reviewed: Ezetimibe (Ezétrol) is a selective cholesterol absorption inhibitor. Co-administration of ezetimibe with low dose of statins shows LDL lowering comparable to that of the highest dose of the respective statin

Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

NEFAs characteristically are elevated in obese NIDDM patients in both the basal state and after insulin. This elevation might aggravate glycemic control both by decreasing peripheral glucose disposal (glucose-fatty acid cycle), and by increasing HGO. Thus, lowering plasma NEFA levels might improve

Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND The effects of dietary fatty acid supplementation on lipoprotein fatty acid composition have rarely been described. METHODS Sixty-one overweight and obese adults with dyslipidemia and insulin resistance were randomized to placebo, 2g/day extended-release nicotinic acid (ERN), 4g/day

Претходна
1
2
3
4
5
6
7
Следећи

Придружите се нашој
facebook страници

Herbal & Natural Medicine

Најкомплетнија база лековитог биља подржана науком

Ради на 55 језика
Биљни лекови потпомогнути науком
Препознавање биљака по слици
Интерактивна ГПС мапа - означите биље на локацији (ускоро)
Читајте научне публикације повезане са вашом претрагом
Претражите лековито биље по њиховим ефектима
Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима